{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T04:41:01Z","timestamp":1740112861784,"version":"3.37.3"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113362","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T15:03:44Z","timestamp":1729263824000},"page":"113362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["A novel HBc-S230 protein chimeric VLPs induced robust immune responses against SARS-CoV-2"],"prefix":"10.1016","volume":"143","author":[{"given":"Weixu","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianpeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunru","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangqi","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong-Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-1507","authenticated-orcid":false,"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.intimp.2024.113362_b0005","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1016\/j.vaccine.2023.05.016","article-title":"Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials","volume":"41","author":"Smith","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12951-022-01469-8","article-title":"Polymerized porin as a novel delivery platform for coronavirus vaccine","volume":"20","author":"Yang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12929-022-00833-y","article-title":"Dengue and COVID-19: two sides of the same coin","volume":"29","author":"Malavige","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.113362_b0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113362_b0025","doi-asserted-by":"crossref","first-page":"e24479","DOI":"10.1002\/jcla.24479","article-title":"Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine","volume":"36","author":"Feng","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-021-02589-4","article-title":"Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patients","volume":"23","author":"Kaur","year":"2022","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113362_b0035","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1002\/jmv.27820","article-title":"Comprehensive role of SARS-CoV-2 spike glycoprotein in regulating host signaling pathway","volume":"94","author":"Banerjee","year":"2022","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113362_b0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.14202\/vetworld.2022.565-589","article-title":"Experimental and natural infections of severe acute respiratory syndrome-related coronavirus 2 in pets and wild and farm animals","volume":"15","author":"Mastutik","year":"2022","journal-title":"Veterinary World."},{"issue":"8","key":"10.1016\/j.intimp.2024.113362_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104722","article-title":"Progressive membrane-binding mechanism of SARS-CoV-2 variant spike proteins","volume":"25","author":"Overduin","year":"2022","journal-title":"iScience."},{"issue":"4","key":"10.1016\/j.intimp.2024.113362_b0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bpj.2023.01.016","article-title":"Interactions of SARS-CoV-2 and MERS-CoV fusion peptides measured using single-molecule force methods","volume":"122","author":"Qiu","year":"2023","journal-title":"Biophys. J ."},{"issue":"5","key":"10.1016\/j.intimp.2024.113362_b0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41423-022-00845-6","article-title":"Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells","volume":"19","author":"Hong","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.113362_b0060","article-title":"'All In One' SARS-CoV-2 variant recognition platform: Machine learning-enabled point of care diagnostics","volume":"10","author":"Beduk","year":"2022","journal-title":"Biosensors & Bioelectronics: X"},{"issue":"8","key":"10.1016\/j.intimp.2024.113362_b0065","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.3390\/v7082818","article-title":"Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes","volume":"7","author":"Gedvilaite","year":"2015","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.intimp.2024.113362_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11020462","article-title":"Oral and Subcutaneous Immunization with a Plant-Produced Mouse-Specific Zona Pellucida 3 Peptide Presented on Hepatitis B Core Antigen Virus-like Particles","volume":"11","author":"Ghasemian","year":"2023","journal-title":"Vaccines."},{"key":"10.1016\/j.intimp.2024.113362_b0075","doi-asserted-by":"crossref","first-page":"1088852","DOI":"10.3389\/fimmu.2023.1088852","article-title":"Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system","volume":"14","author":"Armero-Gimenez","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12934-023-02043-z","article-title":"Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice","volume":"22","author":"Sazegari","year":"2023","journal-title":"Microb. Cell Fact."},{"issue":"52","key":"10.1016\/j.intimp.2024.113362_b0085","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1016\/j.vaccine.2022.10.069","article-title":"A novel multi-epitope vaccine of HPV16 E5E6E7 oncoprotein delivered by HBc VLPs induced efficient prophylactic and therapeutic antitumor immunity in tumor mice model","volume":"40","author":"Qi","year":"2022","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.intimp.2024.113362_b0090","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.vaccine.2017.04.031","article-title":"Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.intimp.2024.113362_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050919","article-title":"Elucidating Pathway and Anesthetic Mechanism of Action of Clove Oil Nanoformulations in Fish","volume":"14","author":"Kheawfu","year":"2022","journal-title":"Pharmaceutics."},{"issue":"8","key":"10.1016\/j.intimp.2024.113362_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9081744","article-title":"SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes","volume":"9","author":"Kalkeri","year":"2021","journal-title":"Microorganisms."},{"key":"10.1016\/j.intimp.2024.113362_b0105","article-title":"Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study","volume":"11","author":"S\u00e1ez-Llorens","year":"2022","journal-title":"Vaccine: X."},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0110","doi-asserted-by":"crossref","first-page":"e12890","DOI":"10.1016\/j.heliyon.2023.e12890","article-title":"Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon."},{"issue":"6","key":"10.1016\/j.intimp.2024.113362_b0115","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.113362_b0120","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/619480","article-title":"Molecular and biochemical characterization of recombinant guinea pig tumor necrosis factor-alpha","volume":"2015","author":"Dirisala","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2024.113362_b0125","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3389\/fimmu.2017.01797","article-title":"Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1\/K(b) Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome","volume":"8","author":"Tang","year":"2017","journal-title":"Front. Immunol."},{"issue":"W1","key":"10.1016\/j.intimp.2024.113362_b0130","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkz413","article-title":"SEPPA 3.0-enhanced spatial epitope prediction enabling glycoprotein antigens","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113362_b0135","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/all.15305","article-title":"Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants","volume":"77","author":"Gattinger","year":"2022","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41541-023-00610-4","article-title":"Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice","volume":"8","author":"Nanishi","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.intimp.2024.113362_b0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12967-015-0524-y","article-title":"A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma","volume":"13","author":"Lin","year":"2015","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7150\/ijbs.7585","article-title":"NOD2 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis","volume":"10","author":"Wang","year":"2013","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.113362_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9060588","article-title":"Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans","volume":"9","author":"Yu","year":"2021","journal-title":"Vaccines."},{"key":"10.1016\/j.intimp.2024.113362_b0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1743-422X-8-333","article-title":"Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice","volume":"8","author":"Zhang","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.intimp.2024.113362_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100814","article-title":"Use of convalescent plasma therapy in eight individuals with mild COVID-19","volume":"39","author":"Ji","year":"2021","journal-title":"New Microbes New Infect."},{"key":"10.1016\/j.intimp.2024.113362_b0170","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fmicb.2020.02020","article-title":"Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay","volume":"11","author":"Almahboub","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2024.113362_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2022.102527","article-title":"Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response","volume":"41","author":"Long","year":"2022","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.113362_b0180","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.vaccine.2017.12.053","article-title":"A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles","volume":"36","author":"Ramirez","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2024.113362_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10040492","article-title":"Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children","volume":"10","author":"Burns","year":"2022","journal-title":"Vaccines."},{"issue":"11","key":"10.1016\/j.intimp.2024.113362_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9111357","article-title":"Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine","volume":"9","author":"Ferrari","year":"2021","journal-title":"Vaccines."},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0195","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1038\/s41467-022-30864-w","article-title":"Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials","volume":"13","author":"Xin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.113362_b0200","unstructured":"Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of Antibody Immunity to SARS-CoV-2. bioRxiv : the preprint server for biology. 2021."},{"issue":"5","key":"10.1016\/j.intimp.2024.113362_b0205","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12250-021-00360-4","article-title":"Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months","volume":"36","author":"Zheng","year":"2021","journal-title":"Virol. Sin."},{"issue":"18","key":"10.1016\/j.intimp.2024.113362_b0210","doi-asserted-by":"crossref","first-page":"eabq7866","DOI":"10.1126\/sciadv.abq7866","article-title":"A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo","volume":"9","author":"Guo","year":"2023","journal-title":"Sci. Adv."},{"issue":"5 Suppl","key":"10.1016\/j.intimp.2024.113362_b0215","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1097\/01.CCM.0000127036.27343.48","article-title":"Why do animal models (sometimes) fail to mimic human sepsis?","volume":"32","author":"Esmon","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2024.113362_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.949917","article-title":"Construction and properties of the silk fibroin and polypropylene composite biological mesh for abdominal incisional hernia repair","volume":"10","author":"Luan","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0225","doi-asserted-by":"crossref","first-page":"e2498","DOI":"10.1002\/rmv.2498","article-title":"Virus-like particles as powerful vaccination strategy against human viruses","volume":"34","author":"Hadj Hassine","year":"2024","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.intimp.2024.113362_b0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2018.08.007","article-title":"Use of plant viruses and virus-like particles for the creation of novel vaccines","volume":"145","author":"Balke","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2024.113362_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines6030037","article-title":"Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System","volume":"6","author":"Mohsen","year":"2018","journal-title":"Vaccines."},{"key":"10.1016\/j.intimp.2024.113362_b0240","doi-asserted-by":"crossref","unstructured":"Crisci E, B\u00e1rcena J, Montoya M. Virus-like particle-based vaccines for animal viral infections. Inmunologia (Barcelona, Spain : 1987). 2013;32(3):102-116.","DOI":"10.1016\/j.inmuno.2012.08.002"},{"issue":"1","key":"10.1016\/j.intimp.2024.113362_b0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41541-023-00612-2","article-title":"Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19","volume":"8","author":"Kaplonek","year":"2023","journal-title":"npj Vaccines"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924018848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924018848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:31:12Z","timestamp":1736303472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924018848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"alternative-id":["S1567576924018848"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113362","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel HBc-S230 protein chimeric VLPs induced robust immune responses against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113362"}}